IP Library Patent Application 16521054
Patent Application
App. No. 16/521,054

FERMENTATION PROCESS FOR PRODUCING MONOSACCHARIDES IN FREE FORM FROM NUCLEOTIDE-ACTIVATED SUGARS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/521,054
Abstract

The present invention relates to a process for producing a monosaccharide, e.g. L-fucose, in free form using a microbial fermentation process. The used microorganism exhibits hydrolase activity on nucleotide-activated sugars and releases the monosaccharide in an unmodified free form. The free monosaccharide is retrieved from the supernatant of the cultivated microorganism.

Claims (20)

1 . Process for producing a monosaccharide of interest in free form using a microorganism, the process comprising

a.) providing a microorganism for the synthesis of the monosaccharide comprising an enzyme capable of catalyzing the hydrolysis of a nucleotide-activated monosaccharide to release the monosaccharide of interest from the nucleotide-activated monosaccharide, and

b.) cultivating the microorganism in a medium suitable for growing the microorganism, wherein the microorganism is unable to metabolize the monosaccharide to a significant extent, so that the monosaccharide of interest accumulates during cultivation.

2 . The process of claim 1 , wherein a recombinant microorganism is used, wherein the recombinant microorganism comprises a heterologous nucleic acid encoding an enzyme capable of catalyzing the hydrolysis of a nucleotide-activated monosaccharide.

3 . The process of claim 1 , wherein the enzyme is a glycosyltransferase, optionally a fucosyltransferase, the enzyme being able to catalyze the hydrolysis of the nucleotide-activated monosaccharide GDP-fucose in the absence of an acceptor molecule.

4 . The process of claim 1 , wherein the enzyme is a variant of the 2-fucosyltransferase encoded by the wbgL gene from Escherichia coli , or a variant of the 1,2-fucosyltransferase encoded by the futC gene from Helicobacter pylori , the variant carrying at least one, optionally at least two, and optionally more than two modifications as compared to the wild type 2-fucosyltransferase encoded by the wbgL gene or to the wild type 1,2-fucosyltransferase encoded by the futC gene, respectively, the modification leading to an increased hydrolizing activity of the enzyme.

5 . The process of claim 4 , wherein at least one modification is an amino acid substitution.

6 . The process of claim 1 , wherein the microorganism is further modified to have inactivated or severely reduced or to lack catabolic pathways leading to the degradation of the produced monosaccharide.

7 . The process of claim 1 , wherein the microorganism is further modified to have inactivated or severely reduced or to lack genes involved in the catabolism of L-fucose.

8 . The process of claim 1 , wherein the microorganism is further modified to overexpress at least one gene involved in the biosynthesis of the nucleotide-activated monosaccharide to improve supply of the nucleotide-activated monosaccharide of the monosaccharide.

9 . The process of claim 1 , wherein at least one gene involved in the biosynthesis of GDP-fucose, GDP-mannose or GDP-rhamnose is overexpressed to improve supply of GDP-fucose, GDP-mannose or GDP-rhamnose, respectively.

10 . The process of claim 8 , wherein the at least one gene is heterologous or homologous.

11 . The process of claim 1 , wherein the microorganism is further modified to have inactivated or reduced competing pathways for the nucleotide-activated monosaccharide.

12 . The process of claim 1 , wherein the monosaccharide produced is selected from L-fucose, L-rhamnose, or L-mannose.

13 . The process of claim 1 , wherein the microorganism is cultivated in a medium containing an inexpensive carbon source that is selected but not limited to glycerol, sucrose, glucose, fructose, molasse, xylose, cellulose, syngas, corn-syrup or lactose.

14 . The process of claim 1 , wherein the microorganism is further modified to express a phosphatase, in case where the monosaccharide is released in a phosphorylated form by the enzyme.

15 . Recombinant microorganism comprising a heterologous enzyme capable of catalyzing the hydrolysis of a nucleotide-activated monosaccharide and releasing the monosaccharide from the nucleotide-activated monosaccharide in the absence of an acceptor molecule, wherein the enzyme is a glycosyltransferase, optionally a fucosyltransferase.

16 . The recombinant microorganism of claim 15 , wherein the enzyme is a variant of the 2-fucosyltransferase encoded by the wbgL gene, or a variant of the 1,2-fucosyltransferase encoded by the futC gene from Helicobacter pylori , the variant carrying at least one, optionally at least two, and optionally more than two modifications as compared to the wild type 2-fucosyltransferase encoded by the wbgL gene or to the wild type 1,2-fucosyltransferase encoded by the futC gene, respectively, the modification leading to an increased hydrolizing activity of the enzyme.

17 . The recombinant microorganism of claim 15 , that is further modified to comprise heterologous genes encoding phosphomannomutase, mannose-1-phosphate guanosyltransferase, GDP-mannose-4,6-dehydratase, and GDP-L-fucose synthase.

18 . The process of claim 1 , wherein or recombinant host microorganism produced therefrom wherein the host microorganism is an Escherichia coli strain, Corynebacterium spp., Clostridium spp., Bacillus spp. Pseudomonas spp. Lactobacillus spp. or a Saccharomyces sp. strain.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Apr 23, 2024
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 067189/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2019
From: JENNEWEIN, STEFAN; PARSCHAT, KATJA
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 049849/0965 →